Development of Novel Adhesive Sports Tape Modular to Facilitate Use of Discomfort
1 other identifier
interventional
86
1 country
1
Brief Summary
Special metals (e.g. Germanium, Titanium, and π element) can be used to produce far-infrared radiation. The applications of these metals in promoting blood circulation are worth investigating. This clinical trial recruited subjects for using tape made up of Ge, Ti, and π element developed by Green Energy Nano Technology Co., Ltd. We assumed that the experimental tape can improve the participants' peripheral blood circulation and their quality of life. In this clinical trial, the clinical efficacy and safety of the test products were assessed using physical examination and questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2017
CompletedStudy Start
First participant enrolled
March 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2019
CompletedFirst Posted
Study publicly available on registry
July 19, 2019
CompletedSeptember 9, 2020
September 1, 2020
1.2 years
December 18, 2017
September 8, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Ankle-Brachial Pressure Index
Detect the pressure difference in percentage between brachial pressure and ankle pressure by the pulse volume record and ultrasound device.
1 day
MVO/SVC
The ratio of maximum venous outflow (MVO) to the segmental venous capacitance (SVC)
1 day
Visual Analog Scale (VAS) Pain
VAS is measurement instrument for describing pain severity or intensity. The pain scale is range from 0 to 10, representing "no hurt" to "hurt worst", respectively.
1 day
Secondary Outcomes (1)
Kidney Disease Quality of Life
Day 0 (before intervention) and Day 7 (after using the intervention for 7 days)
Study Arms (2)
treatment group
EXPERIMENTALthe data is collected from the same participant after the intervention.
Control group
NO INTERVENTIONThe Collect the data from the same participant before the intervention as control
Interventions
Eligibility Criteria
You may qualify if:
- Cardiovascular disease (deep Vein Thrombosis or Chronic venous insufficiency)
You may not qualify if:
- Vulnerable populations
- wound at lower limb which can not take the intervention
- one can not make express consent clearly
- dyslexia
- who need physical assistance during ambulation
- nonfunctional ambulator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Defense of Medical Center, Tri-Service General Hospital
Taipei, 114, Taiwan
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 18, 2017
First Posted
July 19, 2019
Study Start
March 12, 2018
Primary Completion
May 20, 2019
Study Completion
June 20, 2019
Last Updated
September 9, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share